Mohamed Elgendy

Dr. Mohamed Elgendy is a dedicated physician with extensive experience in multidisciplinary oncology drug research and development. Renowned for his specialized expertise in cell therapy, he has been instrumental in advancing first-in-human (FIH) AR-T treatments, particularly targeting advanced solid tumors.

With a compassionate approach to healthcare, Dr. Elgendy channels over a decade of diverse oncology research experience into making a meaningful difference in the lives of cancer patients. Beyond his professional achievements, he treasures time with his family and three young children. An avid reader, soccer enthusiast, and table tennis fan, Dr. Elgendy brings his characteristic energy and dedication to every endeavor.